Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by barcodewhizon Feb 21, 2018 2:18am
396 Views
Post# 27592179

NR

NRI am quite comfortable saying that this PR is one of the most concise and polished NR’s I have seen in my 20 yrs..(yes 20 yrs ) in this stock...And thats coming from one of the biggest critics of this company’s communication quality and strategy

I applaud the rationalization of the periphery trials and the new focus on the largest value drivers that have the best regulatory pathways with the best prospective opportunities and outcomes.  This is what many of us have been asking for... albeit still
missing the big monetization deal....    But one can now see a way thru, and most importantly a number of means to properly capitalize the company and fund the future without hurting existing shareholders.  In fact,  as I have been sayimg, I firmly believe this path will remove doubt, build confidence in the plan and rid us of this relentless short attack by unlocking the value thats been created and suppressed.... and this will all come at the hands of a world class syndicate of primarily US Investment Banks,  the likes of which this company has never seen before.

You only need look to look at the respective  pipelines and valuations of Fibrogen and  Galapagos to see what even a partial unlock of value can do for Prometic...particularly when you factor in that there  are those on Wall Street and in industry who are beginning to realize and believe that Prometic’s pipeline is arguably more advanced and likely has greater prospects.
Make no mistake and start believing, Prometic has arrived in the USA and the big boys are about to get on board

Bullboard Posts